STUDIES OF THE TREATMENT OF THE METRITIS-MASTITIS-AGALACTIA SYNDROME OF SOWS WITH VOREN(R) IN COMBINATION WITH ANTIBIOTICS AND SYMPTOMATIC TREATMENT

A randomized clinical trial was conducted on 90 sows suffering from th e metritis-mastitis-agalactia syndrome to determine the efficacy of a single domain of Voren(R) administered in combination with basic thera py. The study was conducted using a blind protocol and a placebo was a dministered to controls. A minimum litter size of 6 live piglets and p resence of clinical signs of MMA with a minimum rectal temperature of 39.3-degrees-C were used criteria for inclusion to the trial. All anim als received a basic therapy comprising 2.5 Mio IU Penthacillin intram uscularly, 1 g chloramphenicol and 0.5 g neomycin sulphate intra-uteri ne and 20 IU oxytocin intramuscularly. Forty-two sows received 0.02 mg dexamethasone-21-isonicotinate (Voren(R))/kg bodyweight and the remai ning 48 sows received a similar volume of a placebo intramuscularly.